Asunto(s)
Aterosclerosis/historia , Epidemias/historia , Hipolipemiantes/historia , Niacina/historia , Pelagra/historia , Aterosclerosis/epidemiología , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Hipolipemiantes/uso terapéutico , Niacina/uso terapéutico , Pelagra/etiología , Pelagra/terapiaRESUMEN
The aim was to describe the discovery of niacin, biotin, and pantothenic acid. By the 1920s, it became apparent that 'water-soluble B' (vitamin B) is not a single substance. In particular, fresh yeast could prevent both beriberi and pellagra, but the 'antipolyneuritis factor' in yeast is thermolabile, while the antipellagra factor is heat stable, suggesting that there are at least two water-soluble vitamins. Various terms were proposed for these water-soluble factors, but vitamins B(1) and B(2) were most widely used to refer to the thermolabile and heat-stable factors, respectively. Although vitamin B(1) proved to be a single chemical substance (thiamin), vitamin B(2) was ultimately found to be a complex of several chemically unrelated heat-stable factors, including niacin, biotin, and pantothenic acid. Recognition that niacin is a vitamin in the early 20th century resulted from efforts to understand and treat a widespread human disease - pellagra. American epidemiologist and US Public Health Service officer Joseph Goldberger (1874-1929) had been instrumental to elucidating the nutritional basis for pellagra. Goldberger conducted a classic series of observational and experimental studies in humans, combined with an extensive series of experiments with an animal model of the condition (black tongue in dogs). In contrast, recognition that biotin and pantothenic acid are vitamins occurred somewhat later as a result of efforts to understand microbial growth factors. The metabolic roles in humans of these latter substances were ultimately elucidated by human experiments using particular toxins and by studies of rare inborn errors of metabolism. Symptomatic nutritional deficiencies of biotin and pantothenic acid were, and continue to be, rare.
Asunto(s)
Biotina/historia , Niacina/historia , Ácido Pantoténico/historia , Animales , Biotina/química , Biotina/deficiencia , Biotina/farmacología , Deficiencia de Biotinidasa/tratamiento farmacológico , Deficiencia de Biotinidasa/fisiopatología , Perros , Historia del Siglo XX , Humanos , Niacina/química , Niacina/farmacología , Ácido Pantoténico/química , Ácido Pantoténico/deficiencia , Ácido Pantoténico/farmacología , Pelagra/tratamiento farmacológico , Pelagra/fisiopatología , Vitaminas/química , Vitaminas/farmacologíaRESUMEN
Working in a psychiatrically innovative environment created by the Government of Saskatchewan, Canada, Abram Hoffer and Humphry F. Osmond enunciated the adrenochrome hypothesis for the biogenesis of schizophrenia in 1952, slightly later proposing and, apparently, demonstrating, in a double-blind study, that the symptoms of the illness could be reversed by administering large doses of niacin. After placing the hypothesis within its ideological framework, the author describes its emergence and elaboration and discusses the empirical evidence brought against it. Hoffer's idiosyncratic diagnostic procedures, especially his creation and use of a supposed biochemical marker for schizophrenia, are examined. The author argues that Hoffer's conceptualization of schizophrenia, as well as his treatment approach, depended on a tautology. Following David Healy, the author treats the adrenochrome hypothesis as a version of a transmethylation theory, thus incorporating it into mainstream psychopharmacology.
Asunto(s)
Adrenocromo/historia , Alucinógenos/historia , Teoría Psicológica , Esquizofrenia/historia , Historia del Siglo XX , Humanos , Dietilamida del Ácido Lisérgico/historia , Modelos Psicológicos , Niacina/historia , Niacina/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/etiología , Complejo Vitamínico B/historia , Complejo Vitamínico B/uso terapéuticoAsunto(s)
Enfermedades de los Perros/historia , Niacina/historia , Pelagra/historia , Animales , Suplementos Dietéticos/historia , Enfermedades de los Perros/tratamiento farmacológico , Perros , Historia del Siglo XX , Niacina/uso terapéutico , Pelagra/tratamiento farmacológico , Pelagra/veterinariaAsunto(s)
Cobre/historia , Niacina/historia , Anemia/tratamiento farmacológico , Anemia/historia , Animales , Cobre/uso terapéutico , Suplementos Dietéticos/historia , Historia del Siglo XX , Hierro/historia , Hierro/uso terapéutico , Niacina/uso terapéutico , Fenómenos Fisiológicos de la Nutrición , Pelagra/historia , Pelagra/prevención & control , Pelagra/veterinaria , Estados UnidosRESUMEN
Virgil Sydenstricker was a member of a notable American family which included authoress Pearl S. Buck and the eminent epidemiologist Edgar Sydenstricker. Dr. Sydenstricker's contributions in the fields of hematology and nutritional disease are legion. His landmark work in sickle cell anemia characterized a definite symptom complex with specific hematologic findings and inheritance pattern. He wrote on the complications of malnutrition and attempted to delineate the specific effects of individual nutritional factors. Dr. Sydenstricker and his associate H. M. Cleckley first described the syndrome of niacin deficiency encephalopathy. Today, the syndrome is still occasionally reported. Niacin deficiency should be considered when unexplained acute confusional states or neurologic deficits occur in the setting of malnutrition, antituberculous drug use, or chronic partial nutritional deficiency with acute increase in metabolic demand.